KoreaStockCheckBACKGROUND CHECKS · KRX FILINGS

How to Buy Korean Stocks as a Foreigner (2026 Guide)

KOREASTOCKCHECK MAGAZINE · UPDATED AUGUST 2026

For decades, buying a stock on the Korea Exchange meant paperwork most retail investors never finished. Then Korea scrapped its foreign-investor registration system in December 2023, allowed omnibus accounts, and in May 2026 started requiring its larger listed companies to file in English. International brokers have been plugging in since. The result is three workable routes in, each with a different trade-off.

Your three ways in

ROUTEWHAT YOU GETTRADE-OFF
Direct KRX sharesThe original listed stock, full universe (KOSPI + KOSDAQ, ~2,700 names)Seoul market hours, KRW conversion
ADRs / GDRsA depositary receipt on your home exchange, in USD/EUROnly a handful of large caps; ratios and liquidity vary
Korea ETFsOne-ticket exposure (e.g. broad-market Korea funds)Top holdings are dominated by Samsung Electronics and SK Hynix

Which brokers offer direct KRX access

Verified as of August 2026:

BROKERKRX DIRECT ACCESSNOTES
Interactive BrokersYes, since May 7, 20262,700+ KOSPI/KOSDAQ names; not available to Korea residents or IBKR Japan/India entities
moomoo (Singapore)Yes, since late 2025Under Korea's omnibus-account guidelines
Futu (Hong Kong)Yesmoomoo's parent; Hong Kong clients
Robinhood, Tiger BrokersNo direct accessKorea ETFs and some ADRs only

Other brokers may add access as Korea's opening continues. Check whether your broker lists "KRX" or "Korea Exchange" among its markets, and if it doesn't say so explicitly, assume the answer is no.

The mechanics nobody warns you about

Buying from the US, Canada, Australia, Singapore, India

The pattern is the same everywhere: if a globally available broker such as Interactive Brokers operates in your country, you get direct KRX access through it, and otherwise you're limited to ADRs and ETFs on your local exchange. Singapore additionally has moomoo SG with direct access. Availability and account rules are set by each broker's local entity, so verify on the broker's own market list, not on a blog post (including this one).

The research stack most foreigners settle on

Once your broker works, the toolkit that comes up again and again is TradingView (covers KRX symbols, with English screening by market cap, P/E and ROE), MarketScreener (quick English company profiles), English DART (official filings, though only larger companies must file in English, so coverage is partial), and KRX's global site for market rules. As far as finding stocks and reading numbers go, it's a good stack.

What none of these four do is answer one important question the standard research stack often misses: what has this company actually filed? Serial capital raises, convertible-bond churn, auditor changes. The screener never shows them, and English DART misses most of the market. That's the fifth step, and it has a name: a background check (the full research-stack guide walks through all five steps).

The step most foreigners skip: reading the filings

Korean filings are public, but they're in Korean. In our historical validation data, many delistings for cause were preceded by repeated financing, audit or exchange-status events: serial capital raises, convertible-bond churn, capital reductions, auditor red flags. Many of those filings receive little or delayed English-language coverage, and while Korea's English-disclosure mandate now covers larger companies, most of the market still files in Korean only.

That's the gap KoreaStockCheck covers: an English index of any listed Korean company's public filing history, built from DART records going back to 2011, with every claim linked to the original document. Look up a company's filing history →

This guide is information, not investment advice or a recommendation of any broker. Rules cited are per KRX/FSC as of August 2026; verify current parameters with the exchange and your broker.

Data: DART — Korea's official corporate disclosure system. Validated against official KRX delisting records. KoreaStockCheck provides source-linked corporate filing data, rule-based filing-risk classifications and historical validation statistics. It does not provide buy, sell or hold recommendations, price targets or personalized investment advice. Every claim links to the original filing. Missing a market, a data field, or a feature? Tell us what you need.
Pricing · Why · Samples · Method · Member area preview  ·  Magazine · About · Contact · Terms · Privacy · Refunds